R. Saini

Publications27
h-index13
Citations364
Highly Influential Citations4
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • S. Sanyal
  • 238 Publications, 1,998 Citations
  • R. Reeves
  • 88 Publications, 2,373 Citations
  • M. Weir
  • 786 Publications, 23,942 Citations
  • M. Weber
  • 689 Publications, 31,355 Citations
  • Publications
  • Influence
Chemopreventive effect of nonsteroidal anti-inflammatory drugs on 9,10-dimethylbenz[a]anthracene-induced lung carcinogenesis in mice.
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, celecoxib, and etoricoxib were studied as chemopreventive agents in lung cancer in mice induced by 9,10-dimethylbenz[a]anthracene… Expand
  • 5
  • 2
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies.
An analysis of 5 multicenter, open-label studies was conducted to evaluate the long-term safety and efficacy of irbesartan in 1,006 patients with seated diastolic blood pressure (SeDBP) 95-110 mm Hg.… Expand
  • 28
  • 1
OMAPATRILAT COMPARED WITH LISINOPRIL IN TREATMENT OF HYPERTENSION AS ASSESSED BY AMBULATORY BLOOD PRESSURE MONITORING: P2.25
  • 15
  • 1
Management of hypertension: the role of combination therapy.
The complementary action of angiotensin converting enzyme inhibitors and diuretics in the treatment of hypertension has been demonstrated in a number of studies of fosinopril and hydrochlorothiazide… Expand
  • 43
The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide
The long-term safety, tolerability, and antihypertensive effects of irbesartan/hydrochlorothiazide (HCTZ) were assessed in hypertensive patients (seated diastolic blood pressure [SeDBP] 95–110 mm… Expand
  • 45
The Antihypertensive Efficacy of the Combination of Irbesartan and Hydrochlorotfflazide Assessed by 24-Hour Ambulatory Blood Pressure Monitoring
In a multicenter, double-blind, randomized trial, 178 patients with ambulatory diastolic blood pressure (BP) ⩾ 85 mm Hg and seated diastolic BP (SeDBP) 95–110 mm Hg received either once-daily… Expand
  • 31
The safety and 24-hour antihypertensive efficacy of the vasopeptidase inhibitor Omapatrilat: a pilot study
  • 21
Efficacy and safety of omapatrilat with hydrochlorothiazide for the treatment of hypertension in subjects nonresponsive to hydrochlorothiazide alone.
This multicenter, double-blind study evaluated efficacy and safety of the vasopeptidase inhibitor omapatrilat, which simultaneously inhibits neutral endopeptidase and angiotensin converting enzyme,… Expand
  • 22
Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension
SummaryThis study compared the efficacy and tolerability of two dose-titrated regimens of irbesartan, an angiotensin II receptor antagonist selective for the AT1 subtype, vs placebo in hypertensive… Expand
  • 24
Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts
Various immunomodulating agents have been used in the treatment of recalcitrant warts, but none is uniformly effective. Drugs like cimetidine and levamisole have been tried with varying success… Expand
  • 31